Literature DB >> 12373574

Is glycogen storage disease 1a associated with atherosclerosis?

Froukje L Ubels1, Jan Peter Rake, Joris P J Slaets, G Peter A Smit, Andries J Smit.   

Abstract

UNLABELLED: Deficiency of microsomal glucose-6-phosphatase in liver and kidney leads to glycogen storage disease type 1a (GSD 1a). Notwithstanding intensive dietary therapy, moderate to severe dyslipidaemia and microalbuminuria, both known atherosclerotic risk factors, remain present. Although more patients reach adult age, no information is still available about accelerated atherosclerosis. The aim of our study was to investigate whether GSD 1a was associated with premature atherosclerosis. In nine adolescent patients (mean age 22.7+/-3.4 years) and nine matched healthy control subjects, lipid profile, blood pressure, ankle-brachial indices, aortic distensibility and intima-media thickness (IMT) of the carotid and femoral arteries were determined. As expected, lipid profiles were significantly unfavourable in the patient group compared with the control group. No differences were found in blood pressure, ankle-brachial indices and aortic distensibility between both groups. IMT segments were comparable in both groups, with even thinner segments in the patient group. In different multivariate models, GSD 1a remained an independent predictor for a thinner IMT (R(2)=0.90; beta=-0.69; P=0.018).
CONCLUSION: glycogen storage disease type 1a is not associated with premature atherosclerosis, despite the existence of longstanding dyslipidaemia and microalbuminuria.

Entities:  

Mesh:

Year:  2002        PMID: 12373574     DOI: 10.1007/s00431-002-1006-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

1.  Increased atherosclerosis in a mouse model of glycogen storage disease type 1a.

Authors:  Anouk M La Rose; Anouk G Groenen; Benedek Halmos; Venetia Bazioti; Martijn G S Rutten; Kishore A Krishnamurthy; Mirjam H Koster; Niels J Kloosterhuis; Marieke Smit; Rick Havinga; Gilles Mithieux; Fabienne Rajas; Folkert Kuipers; Maaike H Oosterveer; Marit Westerterp
Journal:  Mol Genet Metab Rep       Date:  2022-04-21

2.  Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control.

Authors:  A V Bernier; C P Sentner; C E Correia; D W Theriaque; J J Shuster; G P A Smit; D A Weinstein
Journal:  J Inherit Metab Dis       Date:  2008-08-19       Impact factor: 4.982

3.  Vascular dysfunction in glycogen storage disease type I.

Authors:  Angelina V Bernier; Catherine E Correia; Michael J Haller; Douglas W Theriaque; Jonathan J Shuster; David A Weinstein
Journal:  J Pediatr       Date:  2008-12-21       Impact factor: 4.406

4.  Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition.

Authors:  Daniëlle H J Martens; Jan Peter Rake; Gerjan Navis; Vaclav Fidler; Catharina M L van Dael; G Peter A Smit
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-01       Impact factor: 8.237

5.  Total oxidant-scavenging capacities of plasma from glycogen storage disease type Ia patients as measured by cyclic voltammetry, FRAP and luminescence techniques.

Authors:  E Koren; J Lipkin; A Klar; E Hershkovitz; I Ginsburg; R Kohen
Journal:  J Inherit Metab Dis       Date:  2009-10       Impact factor: 4.982

6.  Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia.

Authors:  C Mühlhausen; R Schneppenheim; U Budde; M Merkel; N Muschol; K Ullrich; R Santer
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.750

Review 7.  Glucose-6-phosphatase deficiency.

Authors:  Roseline Froissart; Monique Piraud; Alix Mollet Boudjemline; Christine Vianey-Saban; François Petit; Aurélie Hubert-Buron; Pascale Trioche Eberschweiler; Vincent Gajdos; Philippe Labrune
Journal:  Orphanet J Rare Dis       Date:  2011-05-20       Impact factor: 4.123

Review 8.  Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions.

Authors:  Terry G J Derks; Margreet van Rijn
Journal:  J Inherit Metab Dis       Date:  2015-01-30       Impact factor: 4.982

9.  Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.

Authors:  N C den Hollander; D J Mulder; R Graaff; S R Thorpe; J W Baynes; G P A Smit; A J Smit
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.